tiprankstipranks
OncoTherapy Science, Inc. (JP:4564)
:4564
Japanese Market
4564
OncoTherapy Science
RESEARCH TOOLSreports
Want to see JP:4564 full AI Analyst Report?

OncoTherapy Science (4564) Income Statement

2 Followers

OncoTherapy Science Income Statement

Last quarter (Q4 2024), OncoTherapy Science's total revenue was ¥186.75M, a decrease of -7.31% from the same quarter last year. In Q4, OncoTherapy Science's net income was ¥-98.05M. See OncoTherapy Science’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 22Mar 21
Total Revenue
¥ 808.53M¥ 750.05M¥ 610.12M¥ 1.13B¥ 332.48M
Gross Profit
¥ 13.96M¥ -12.76M¥ -177.72M¥ 41.69M¥ 19.54M
Operating Expenses
¥ 824.35M¥ 785.18M¥ 943.08M¥ 1.15B¥ 1.66B
Depreciation and Amortization
¥ 0.00¥ 797.00M¥ 2.00K¥ 16.00M¥ 49.01M
EBITDA
¥ -810.38M¥ -811.92M¥ -1.29B¥ -1.09B¥ -1.59B
Operating Income
¥ -810.38M¥ -797.94M¥ -1.12B¥ -1.11B¥ -1.64B
Other Income/Expenses
¥ -98.09M¥ -15.19M¥ -164.91M¥ -10.01M¥ 77.92M
Pretax Income
¥ -908.48M¥ -813.13M¥ -1.29B¥ -1.12B¥ -1.56B
Net Income
¥ -910.64M¥ -815.28M¥ -1.29B¥ -1.12B¥ -1.56B
Per Share Metrics
Basic EPS
¥ -2.77¥ -3.12¥ -6.05¥ -5.81¥ -8.86
Diluted EPS
¥ -2.77¥ -3.12¥ -6.05¥ -5.81¥ -8.86
Weighted Average Shares Outstanding
 328.24M 261.14M 212.78M 192.64M 176.33M
Weighted Average Shares Outstanding (Diluted)
 328.24M 261.14M 212.78M 192.64M 176.33M
Currency in JPY

OncoTherapy Science Earnings and Revenue History